1,096 results on '"McLaughlin, Vallerie V."'
Search Results
2. Safety of Macitentan for the Treatment of Portopulmonary Hypertension: Real-World Evidence from the Combined OPUS/OrPHeUS Studies
3. Using a knowledge translation program to facilitate guideline‐ and evidence‐based patient management: the PAH‐QuERI Extension Program
4. Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial
5. Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association
6. Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry Enrollment Characteristics and 1-Year Follow-up
7. Abstract 13038: Predictive Value of Cardiac Function Parameters and NT-proBNP in Patients With Pulmonary Arterial Hypertension (PAH) Treated With Sotatercept in the STELLAR Trial
8. Timely PAH Identification in Adults With Repaired Congenital Heart Disease? The ACHD-QuERI Registry Insights
9. Symptoms Suggestive of Postpulmonary Embolism Syndrome and Utilization of Diagnostic Testing
10. Long-term Survival and Quality of Life: Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry
11. Anatomical Variations in Pulmonary Arterial Branches in Patients Undergoing Evaluation for Chronic Thromboembolic Pulmonary Hypertension
12. Periprocedural Complications With Balloon Pulmonary Angioplasty: Analysis of Global Studies
13. Interventional Imaging Roadmap to Successful Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension
14. Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension
15. Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial
16. Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbidities.
17. Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial.
18. Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines.
19. IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension
20. Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension
21. Performance of DETECT PAH algorithm according to the hemodynamic definition of pulmonary arterial hypertension (PAH) in the 2022 ESC/ERS guidelines
22. Exercise Rehabilitation is Underutilized Among Veterans With Pulmonary Hypertension
23. Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial
24. Risk assessment in pulmonary arterial hypertension: Insights from the GRIPHON study
25. Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension With Oral Prostacyclin Pathway Agents
26. Long-Term Effects of Sotatercept on Right Ventricular Function
27. Late Breaking Abstract - A long-term follow-up (LTFU) study of sotatercept for pulmonary arterial hypertension (PAH)
28. Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial
29. Gender, Racial, and Geographic Disparities in Pulmonary Embolism-related Mortality Nationwide
30. Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial
31. The United States Chronic Thromboembolic Pulmonary Hypertension Registry: Protocol for a Prospective, Longitudinal Study
32. Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trial
33. Pulmonary Hypertension in Women
34. Sex, Racial, and Geographic Disparities in Pulmonary Embolism-related Mortality Nationwide.
35. Recommendations for Screening and Detection of Connective Tissue Disease–Associated Pulmonary Arterial Hypertension
36. Safety of regadenoson stress testing in patients with pulmonary hypertension
37. Temporary treatment interruptions with oral selexipag in pulmonary arterial hypertension: Insights from the Prostacyclin (PGI2) Receptor Agonist in Pulmonary Arterial Hypertension (GRIPHON) study
38. Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality
39. Modern Age Pathology of Pulmonary Arterial Hypertension
40. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
41. RACIAL DISPARITIES IN PULMONARY EMBOLISM MORTALITY AMONGST US ADULTS BEFORE AND DURING COVID-19 PANDEMIC.
42. TAKE MY BREATH AWAY: RARE MIMIC IN THE DIAGNOSIS OF PULMONARY HYPERTENSION
43. SAFETY OF BALLOON PULMONARY ANGIOPLASTY IN THE OUTPATIENT SETTING: THE MICHIGAN MEDICINE EXPERIENCE
44. TEMPORAL MORTALITY TRENDS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION, STROKE, AND PULMONARY EMBOLISM IN THE UNITED STATES
45. Safe and Effective Balloon Pulmonary Angioplasty in the Outpatient Setting: The Michigan Medicine Experience
46. Usefulness of Echocardiography/Doppler to Reliably Predict Elevated Left Ventricular End-Diastolic Pressure in Patients With Pulmonary Hypertension
47. Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension
48. Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study
49. Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension: An STS Database Analysis
50. AV-101, a novel inhaled dry-powder formulation of imatinib, in healthy adult participants: a phase 1 single and multiple ascending dose study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.